Article Information
vol. 31 no. 164
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 7, 2022
- Accepted April 7, 2022
- Published online June 14, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Leila S. Otten1⇑,
- Berber Piet2,
- Michel M. van den Heuvel2,
- Catia Marzolini3,4,
- Robin M.J.M. van Geel5,6,
- Judith L. Gulikers5,6,
- David M. Burger1,
- Jenneke Leentjens7 and
- Rob ter Heine1
- 1Dept of Pharmacy and Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
- 2Dept of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands
- 3Dept of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
- 4Division of Infectious Diseases and Hospital Epidemiology, Depts of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland
- 5Dept of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands
- 6Dept of Internal Medicine and Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
- 7CARIM School for Cardiovascular Disease, Maastricht University, Maastricht, The Netherlands
- Corresponding author: Leila S. Otten (Leila-Sophie.Otten{at}Radboudumc.nl)
Article usage
Altmetrics
Vol 31 Issue 164
Table of Contents
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer
